“…In serotype C, neutralizing antiAbbre6iations: 2D-1 H NMR, two-dimensional proton nuclear magnetic resonance; AA, amino acid residue; AAA, amino acid analysis; Ahx, 6-aminohexanoic acid; AM, 2-[4-aminomethyl-(2,4-dimethoxyphenyl)]phenoxyacetic acid (linker); C A , analyte concentration; DdHa, conformational chemical shift for proton a; DIEA, diisopropylethylamine; DMF, N,N%-dimethylformamide; EDC, N-ethyl-N%-dimethylaminopropylcarbodiimide; EID, enzyme immunodot; EITB, enzyme immuno-electrotransfer blot; ESIMS, electrospray ionization mass spectrometry; Et 3 Si, triethylsilane; Fab, fragment antigen binding; FMDV, foot-and-mouth disease virus; Fmoc, 9-fluorenylmethoxycarbonyl; HPLC, high performance liquid chromatography; IC 50 , 50% inhibition concentration; k a , association rate constant (M − 1 s − 1 ); K A , association thermodynamic constant (M − 1 ); k d , dissociation rate constant (s − 1 ); K D , dissociation thermodynamic constant (M); KLH, keyhole limpet hemocyanin; K i , solution affinity constant (M − 1 ); mAb, monoclonal antibody; MALDI-TOF MS, matrix-assisted laser desorption -time-of-flight mass spectrometry; MBHA, p-methylbenzhydrylamine resin; MeCN, acetonitrile; NHS, N-hydroxysuccinimide; NMM, N-methylmorpholine; NOE, nuclear Overhauser effect; PBS, phosphate buffer saline; R eq , equilibrium response; RI, bulk refractive index; R immob , immobilization response; R max , maximum response (RU); RPLC, reverse phase liquid chromatography; RU, resonance units; SPPS, solid phase peptide synthesis; SPR, surface plasmon resonance; t Bu, tert-butyl; TBTU, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate; TFA, trifluoroacetic acid; TFE, 2,2,2-trifluoroethanol.…”